Report Detail

Summary
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
Market Segment as follows:
By Type
Creams
Tablets
Patches
Rings
By Application
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
By Company
Allergan
Pfizer
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.


Table of Content

    1 Market Overview

    • 1.1 Market Segment Overview
      • 1.1.1 Product Definition
      • 1.1.2 Market by Type
        • 1.1.2.1 Creams
        • 1.1.2.2 Tablets
        • 1.1.2.3 Patches
        • 1.1.2.4 Rings
      • 1.1.3 Market by Application
        • 1.1.3.1 Topical Estrogen
        • 1.1.3.2 Systemic Estrogen
        • 1.1.3.3 Non-hormonal Therapy
    • 1.2 Global and China Market Size
      • 1.2.1 Global Overview
      • 1.2.2 China Overview

    2 Global and China Market by Company

    • 2.1 Global
      • 2.1.1 Global Sales by Company
      • 2.1.2 Global Price by Company
    • 2.2 China
      • 2.2.1 China Sales by Company
      • 2.2.2 China Price by Company

    3 Global and China Market by Type

    • 3.1 Global
      • 3.1.1 Global Sales by Type
      • 3.1.2 Global Price by Type
    • 3.2 China
      • 3.2.1 China Sales by Type
      • 3.2.2 China Price by Type

    4 Global and China Market by Application

    • 4.1 Global
      • 4.1.1 Global Sales by Application
      • 4.1.2 Global Price by Application
    • 4.2 China
      • 4.2.1 China Sales by Application
      • 4.2.2 China Price by Application

    5 China Trade

    • 5.1 Export
    • 5.2 Import

    6 Key Manufacturers

    • 6.1 Allergan
      • 6.1.1 Company Information
      • 6.1.2 Product Specifications
      • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 6.2 Pfizer
    • 6.3 Shionogi
    • 6.4 Novo Nordisk
    • 6.5 Teva Pharmaceutical
    • 6.6 Bayer.

    7 Industry Upstream

    • 7.1 Industry Chain
    • 7.2 Raw Materials

    8 Market Environment

    • 8.1 SWOT
    • 8.2 Porter's Five Forces

    9 Conclusion

    Summary:
    Get latest Market Research Reports on Postmenopausal Vaginal Atrophy Treatment . Industry analysis & Market Report on Postmenopausal Vaginal Atrophy Treatment is a syndicated market report, published as Global and China Postmenopausal Vaginal Atrophy Treatment Market Research by Company, Type & Application 2013-2025. It is complete Research Study and Industry Analysis of Postmenopausal Vaginal Atrophy Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,000.00
    $3,000.00
    $4,000.00
    1,584.00
    2,376.00
    3,168.00
    1,852.00
    2,778.00
    3,704.00
    302,700.00
    454,050.00
    605,400.00
    166,800.00
    250,200.00
    333,600.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report